Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Natural Molecules Improve Markers of Metabolic Syndrome and Climacteric in Menopausal Women

NCT06057896 is registered in ClinicalTrials.gov with Lo.Li.Pharma s.r.l as lead sponsor.

NCT NCT06057896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06057896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Natural Molecules Improve Markers of Metabolic Syndrome and Climacteric in Menopausal Women
Lead sponsor
Lo.Li.Pharma s.r.l
Phase
Observational
Overall status
Completed
Start date
September 30, 2022
Completion date
August 15, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

climacteric syndrome, menopause, metabolic syndrome